Jun Zhu, MD
Dr. Zhu Jun completed his medical degree in 1984, at the Department of Clinical Medicine of the Third Military Medical University.
He then practiced in the Hematology Department of the People’s Liberation Army General Hospital (301 Hospital, Beijing). From 1994 to 1997, he worked on and completed his PhD in Bone Marrow Transplantation at the Hadassah Medical Center of Hebrew University (Jerusalem).
Dr. Zhu practices in the Lymphoma Department of Peking University Cancer Hospital and serves as a specialist and mentor consultant for various professional groups.
Recently, BeiGene Ltd’s lymphoma treatment Brukinsa was approved by the U.S. Food and Drug Administration. This is the first time a drug developed predominantly in China by a Chinese biopharma sponsor has been approved within America. The key clinical trials...